Phase 2 × Urinary Bladder Neoplasms × Carboplatin × Clear all PRESERVE3
Phase 2 Terminated
92 enrolled 24 charts
KEYVIBE-005
Phase 2 Completed
613 enrolled
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Phase 2 Recruiting
63 enrolled
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase 2 Terminated
6 enrolled 12 charts
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
Phase 2 Completed
6 enrolled
VINGEM
Phase 2 Completed
62 enrolled
Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer
Phase 2 Completed
82 enrolled
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
Phase 2 Completed
17 enrolled 10 charts
CVH-CT02
Phase 2 Completed
61 enrolled
High-dose ICE With Amifostine
Phase 2 Completed
24 enrolled
Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Phase 2 Terminated
4 enrolled 6 charts
JASINT1
Phase 2 Completed
69 enrolled
Neoadjuvant ABI-007, Carboplatin and Gemcitabine in Locally Advanced Bladder Cancer
Phase 2 Completed
29 enrolled 11 charts
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
Phase 2 Completed
68 enrolled
Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer
Phase 2 Completed
S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
Phase 2 Completed
77 enrolled 11 charts
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
Phase 2 Completed
7 enrolled
Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer
Phase 2 Completed
40 enrolled